Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Insects|April 27, 2023
The Bioactive Value of <i>Tamarix gallica</i> Honey from Different Geographical OriginsAhmed G Hegazi, Fayez M Al Guthami, Mohamed F A Ramadan, et al.
Journal of Agricultural and Food Chemistry|February 16, 2023
Graphene-Type Materials for the Dispersive Solid-Phase Extraction Step in the QuEChERS Method for the Extraction of Brominated Flame Retardants from <i>Capsicum</i> CultivarsVirgínia Cruz Fernandes, Valentina F Domingues, Marta S Nunes, et al.
Cognitive Processing|June 19, 2024
APOE genotype, hippocampal volume, and cognitive reserve predict improvement by cognitive training in older adults without dementia: a randomized controlled trialPedro Montejo Carrasco, Mercedes Montenegro-Peña, David Prada Crespo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 15, 2024
Single-center analysis of a real-world cohort of patients with metastatic urothelial carcinoma evaluated by NGS: molecular landscape and efficacy of targeted therapiesCésar Gutiérrez Pérez, Enrique Lastra Aras, Patricia Saiz López, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|June 19, 2019
Direct trocar insertion without previous pneumoperitoneum versus insertion after insufflation with Veress needle in laparoscopic gynecological surgery: a prospective cohort studyManuel Pantoja Garrido, Zoraida Frías Sánchez, Ignacio Zapardiel Gutiérrez, et al.
Critical Care Medicine|April 7, 2007
Sepsis incidence and outcome: contrasting the intensive care unit with the hospital wardAndrés Esteban, Fernando Frutos-Vivar, Niall D Ferguson, et al.
Molecular Cancer Therapeutics|January 27, 2019
TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal AntibodiesMaría E Rodríguez-Ruiz, Inmaculada Rodríguez, Lina Mayorga, et al.
Oncoimmunology|July 21, 2022
Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosisÁngela Bella, Leire Arrizabalaga, Claudia Augusta Di Trani, et al.
Journal for Immunotherapy of Cancer|September 7, 2024
MHC class I and II-deficient humanized mice are suitable tools to test the long-term antitumor efficacy of immune checkpoint inhibitors and T-cell engagersIñaki Eguren-Santamaria, Eva Fernández de Piérola, Gracián Camps, et al.
Pageof 9